Pharma Reviews: One year of GST: Crawling, toddling, and on its feet

The pharma industry has registered monthly double-digit growth, which had tanked to negative 2.6% in July when the new tax regime came into force.
Read more: One year of GST: Crawling, toddling, and on its feet

Pharma Reviews: Indian pharma's foray into design of drug delivery devices fuels innovation: Shyamsunder BK

“We have seen a huge drive by the Indian pharma companies and healthcare providers to come up with their own devices for delivery of drugs and ...
Read more: Indian pharma's foray into design of drug delivery devices fuels innovation: Shyamsunder BK

Pharma Reviews: Pharma industry recovers from GST pangs, poised for double digit growth

The Indian pharmaceutical market returned to double digit growth of 10.8 percent in May for the first time in over a year indicating the pangs of ...
Read more: Pharma industry recovers from GST pangs, poised for double digit growth

Pharma Reviews: Lupin tie-up with European Association of Urology

With that objective in mind, Lupin, for the first time ever in the Indian Pharma Industry, has collaborated with EAU (European Association of Urology) to ...
Read more: Lupin tie-up with European Association of Urology

US FDA News: FDA approves novel device for treating breathing difficulty from severe emphysema

FDA approves novel device for treating breathing difficulty from severe emphysema
Read more: FDA approves novel device for treating breathing difficulty from severe emphysema

Pharma Reviews: Separate pavilion will be put up for Pondicherry drug manufacturers at Pharmac South 2018 ...

Tamil Nadu state board of the Indian Drug Manufacturers' Association (TN IDMA) in association with Indian Pharmaceutical Association Tamil Nadu ...
Read more: Separate pavilion will be put up for Pondicherry drug manufacturers at Pharmac South 2018 ...

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new steps to advance health through improvements in nutrition under the agency’s Nutrition Innovation Strategy

Announcement of public meeting to solicit input on plans to modernize food standards and labeling
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new steps to advance health through improvements in nutrition under the agency’s Nutrition Innovation Strategy

Pharma Reviews: Keep Blueprints 'At Home' When Partnering With Chinese Pharma Companies, Advises India

A government report suggests ways for Indian companies to penetrate China's giant healthcare sector, which is poised to hit $1 trillion by 2020.
Read more: Keep Blueprints 'At Home' When Partnering With Chinese Pharma Companies, Advises India

Pharma Reviews: Rupee at 70: How it's bad and how it's good

In a vicious cycle, a depreciated rupee makes oil costlier since its India's chief import. ... All export-based industry benefits from a weak rupee. For example, information technology and pharma companies benefit from a weak rupee ...
Read more: Rupee at 70: How it's bad and how it's good

Pharma Reviews: Government proposes Rs 460 crore for pharmaceuticals sector development

The government is looking at providing assistance to bulk drug industry by setting up common facility centres, proposed as a central sector scheme ...
Read more: Government proposes Rs 460 crore for pharmaceuticals sector development

Pharma Reviews: Earnings will accelerate if no macro headwinds occur: Sailesh Raj Bhan, Reliance Mutual Fund

The sector has come out of its worst phase and is likely to witness an earnings uptrend in the next 1-3 years. The Indian pharma industry is one of the ...
Read more: Earnings will accelerate if no macro headwinds occur: Sailesh Raj Bhan, Reliance Mutual Fund

US FDA News: Statement by FDA Commissioner Scott Gottlieb, M.D., on the importance of conducting proper research to prove safe and effective medical uses for the active chemicals in marijuana and its components

FDA Commissioner Scott Gottlieb, M.D., discusses the importance of conducting proper research to prove safe and effective medical uses for the active chemicals in marijuana and its components.
Read more: Statement by FDA Commissioner Scott Gottlieb, M.D., on the importance of conducting proper research to prove safe and effective medical uses for the active chemicals in marijuana and its components

US FDA News: FDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy

FDA approved Epidiolex (cannabidiol) oral solution, the first drug comprised of an active ingredient derived from marijuana, to treat two rare and severe forms of epilepsy.
Read more: FDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy

Pharma Reviews: Pharma players target US rebound

Mumbai: The domestic pharmaceutical industry is hopeful of a turnaround in the US market in the current financial ... plant of Sun Pharmaceutical Industries Ltd. The green signal will mean India's largest drug firm can now expect the ...
Read more: Pharma players target US rebound

Pharma Reviews: How changes to stock indices affect you

Last Monday, Dr Reddy's Laboratories, a pharmaceutical company, was removed from the ... In India, only 3.4 per cent of the total money is in ETFs.
Read more: How changes to stock indices affect you

Pharma Reviews: This week in MF: Fund houses line up pharma, healthcare funds to tap sector potential

Fund managers believe valuations of pharma companies is cheap, given their ... directly or indirectly from the healthcare and allied sectors in India.
Read more: This week in MF: Fund houses line up pharma, healthcare funds to tap sector potential

Pharma Reviews: This week in MF: Fund houses line up pharma, healthcare funds to tap sector potential

Domestic mutual funds are lining up schemes that invest in pharmaceutical ... directly or indirectly from the healthcare and allied sectors in India.
Read more: This week in MF: Fund houses line up pharma, healthcare funds to tap sector potential

Pharma Reviews: Pharma comes out of shell & it's not more a bitter pill

India's pharmaceutical sector is now popping out from a shell and making a remarkable recovery. Actually, it has been facing several regulatory ...
Read more: Pharma comes out of shell & it's not more a bitter pill

Pharma Reviews: Pharma MSMEs need to adopt backward integration to offset dependence on China: Manoj Palrecha

The micro, small and medium enterprises (MSMEs) in the pharmaceutical sector in India need to adopt backward integration to reduce the ...
Read more: Pharma MSMEs need to adopt backward integration to offset dependence on China: Manoj Palrecha

US FDA News: FDA permits marketing of first catheter-based systems used to create vascular access for hemodialysis patients

FDA permits marketing of first catheter-based systems used to create vascular access for hemodialysis patients
Read more: FDA permits marketing of first catheter-based systems used to create vascular access for hemodialysis patients

US FDA News: Kratom (mitragyna speciosa) powder products by Gaia Ethnobotanical: Recall - Due to Potential Salmonella Contamination

The products have been found by the FDA via sample testing and finding to have salmonella contamination. In lieu of such FDA findings the company has implemented standard operating procedures and sterilization processes in accordance to FDA guidelines
Read more: Kratom (mitragyna speciosa) powder products by Gaia Ethnobotanical: Recall - Due to Potential Salmonella Contamination

Pharma Reviews: Indian companies giving MNCs a run for their money in vitamins

Data from pharma market research firm AIOCD shows that among the top 10 players, firms like Torrent Pharmaceuticals have grown at 13 per cent ...
Read more: Indian companies giving MNCs a run for their money in vitamins

Pharma Reviews: This is what Rakesh Jhunjhunwala has to say about PM Narendra Modi and general elections 2019

Prime Minister Narendra Modi needs a second term to achieve India's full .... Now the Indian pharma industry is entering unknown, risky, but exciting ...
Read more: This is what Rakesh Jhunjhunwala has to say about PM Narendra Modi and general elections 2019

Pharma Reviews: CNBC-TV18 Exclusive: Five key things Rakesh Jhunjhunwala said

He said the flow of local money into Indian markets is just the beginning and ... Now the Indian pharma industry is entering unknown, risky, but exciting ...
Read more: CNBC-TV18 Exclusive: Five key things Rakesh Jhunjhunwala said

Pharma Reviews: 2018 will be the year of consolidation after stellar gains in 2017: Rakesh Jhunjhunwala

We witnessed a massive up move in markets and if the market remains in the ... "Indian pharma industry is entering unknown, but exciting space.".
Read more: 2018 will be the year of consolidation after stellar gains in 2017: Rakesh Jhunjhunwala

Pharma Reviews: Closing Bell: Sensex loses 115 pts, Nifty ends below 10750; ITC, L&T shares drag

Rupee Closing: The Indian rupee closed at 67.99 against the dollar, up 8 paise .... "Indian pharma industry is entering unknown, but exciting space.".
Read more: Closing Bell: Sensex loses 115 pts, Nifty ends below 10750; ITC, L&T shares drag

Pharma Reviews: Market Live: Nifty struggles below 10800; Jhunjhunwala says 2018 is the year of consolidation

He is positive on the domestic branded pharma businesses. "Indian pharma industry is entering unknown, but exciting space." Healthcare majors Sun ...
Read more: Market Live: Nifty struggles below 10800; Jhunjhunwala says 2018 is the year of consolidation

Pharma Reviews: Market Live: Midcap underperforms Sensex; M&M, ONGC, Power Grid top losers

Reliance Industries continued to trade near its record high, which is up over a ... "Indian pharma industry is entering unknown, but exciting space.".
Read more: Market Live: Midcap underperforms Sensex; M&M, ONGC, Power Grid top losers

Pharma Reviews: Alarm bells for engineering, MBA students: AICTE chief says jobs are drying up in IT, BPO sectors

The AICTE chief also has a word of caution for the pharma sector, dismissing the ... Industry veterans have also warned about unskilled Indian youth.
Read more: Alarm bells for engineering, MBA students: AICTE chief says jobs are drying up in IT, BPO sectors

Pharma Reviews: NOW, MAKE IN UZBEKISTAN?

The Indian government's unending search for an alternative to end the over-dependence of Indian pharmaceutical companies on China for APIs has ...
Read more: NOW, MAKE IN UZBEKISTAN?

Pharma Reviews: Portfolio picks: These 5 stocks can be multibaggers in the next 2-3 years

“If the monsoon remains normal as predicted by the India Meteorological Department, we will see ... He is bullish on the IT and pharmaceutical space.
Read more: Portfolio picks: These 5 stocks can be multibaggers in the next 2-3 years

Pharma Reviews: Meet JWL Group's Raaj Jobanputra, the gen-next scion who likes to play it cool

And with a mother who runs her own export business of Indian print ... The dedicated facility for the pharmaceutical industry — JWL's Pharma Hub ...
Read more: Meet JWL Group's Raaj Jobanputra, the gen-next scion who likes to play it cool

Pharma Reviews: Karnataka API players see govt sending wrong signal by proposing to shift API units to Uzbekistan

The Union government is sending wrong signals to the industry by proposing to shift a sizeable part of Indian API (active pharmaceutical ingredient) ...
Read more: Karnataka API players see govt sending wrong signal by proposing to shift API units to Uzbekistan

US FDA News: Various Aortic Endovascular Graft Systems: Letter to Health Care Providers - UPDATE on Type III Endoleaks

Based on new information, the Endologix AFX with Strata device is at greater risk for a Type III endoleak compared to other endovascular AAA graft systems.
Read more: Various Aortic Endovascular Graft Systems: Letter to Health Care Providers - UPDATE on Type III Endoleaks

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on new guidance to help manufacturers implement protections against potential attacks on the U.S. food supply

FDA releases draft guidance to help food manufacturers implement the Intentional Adulteration rule under the FDA Food Safety Modernization Act
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new guidance to help manufacturers implement protections against potential attacks on the U.S. food supply

Pharma Reviews: Top selling drugs face patent expiration between 2018 and 2024, sales worth $251 bn at stake ...

This news is a setback for big pharma companies as they were getting over the patent cliff but could be music for Indian drug makers who are in a race ...
Read more: Top selling drugs face patent expiration between 2018 and 2024, sales worth $251 bn at stake ...

Pharma Reviews: Indian pharma companies should partner Chinese manufacturers for greater market access: Study

Indian pharma companies should enter into strategic alliances and partnership with local manufacturers and distributors in China for getting greater ...
Read more: Indian pharma companies should partner Chinese manufacturers for greater market access: Study

Pharma Reviews: Indian pharma cos should partner Chinese manufacturers for greater market access: Study

The research study on 'Enhancing Indian exports of pharmaceutical products to China' has suggested as many as 17 options to domestic firms for ...
Read more: Indian pharma cos should partner Chinese manufacturers for greater market access: Study

Pharma Reviews: Prabhu releases study on Indian pharma export to China

The study commissioned under the Market Access Initiative Scheme (MAI) aims to help the Indian pharma industry to evolve appropriate and focused ...
Read more: Prabhu releases study on Indian pharma export to China

Pharma Reviews: Government to study ways for boosting pharma export to China

"The Department of Commerce in coordination with Embassy of India at Beijing commissioned a study on enhancing Indian exports of pharmaceutical ...
Read more: Government to study ways for boosting pharma export to China

Pharma Reviews: Global Bureaucracy

Indian pharma industry to evolve appropriate and focused strategy for entry of the Indian generic drugs. The study examines the health care market, ...
Read more: Global Bureaucracy

Pharma Reviews: Study released to help the Indian pharma industry to evolve appropriate and focused strategy for ...

China' s health-care sector continues to grow rapidly with spending projected to grow from $ 357 billion in 2011 to $ 1 trillion in 2020.
Read more: Study released to help the Indian pharma industry to evolve appropriate and focused strategy for ...

Pharma Reviews: Commerce & Industry Minister releases study report on Indian pharma exports to China

Commerce & Industry Minister releases study report on Indian pharma ... a study on “Enhancing Indian Exports of Pharmaceutical products to China” ...
Read more: Commerce & Industry Minister releases study report on Indian pharma exports to China

Pharma Reviews: US still most important market, EMs come next: Saumen Chakraborty, Dr Reddy's

India's big pharma has invested a lot over the last nine years. Would they continue to invest to get into new areas over the next nine years as well?
Read more: US still most important market, EMs come next: Saumen Chakraborty, Dr Reddy's

Pharma Reviews: Wealth creators: Long term investors could buy these 3 pharma stocks

Alembic Pharmaceuticals, Granules India, Marksans Pharma, Ajanta ... A rise in receipts of petroleum, engineering and pharmaceutical products ...
Read more: Wealth creators: Long term investors could buy these 3 pharma stocks

Pharma Reviews: Dr Reddy's gets temporary restraining order on sale of generic Suboxone film in US

Indian pharma major Dr Reddy's Laboratories said today that a US District Court has issued a temporary restraining order on the sale and ...
Read more: Dr Reddy's gets temporary restraining order on sale of generic Suboxone film in US

Pharma Reviews: How Sun Pharma managed to get its Halol facility off the USFDA hook

The large industrial complex came to Sun Pharma's fold post its acquisition of ... “2015 was like a hard landing for large India pharma companies after ...
Read more: How Sun Pharma managed to get its Halol facility off the USFDA hook

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D. and FDA Deputy Commissioner Anna Abram on emerging food innovation, “cultured” food products

Statement from FDA Commissioner Scott Gottlieb, M.D. and FDA Deputy Commissioner Anna Abram on emerging food innovation, “cultured” food products
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. and FDA Deputy Commissioner Anna Abram on emerging food innovation, “cultured” food products

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s efforts to better equip consumers with nutritional information about dietary fiber in their food

Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s efforts to better equip consumers with nutritional information about dietary fiber in their food
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s efforts to better equip consumers with nutritional information about dietary fiber in their food

Pharma Reviews: Disso India - Hyderabad 2018 to take place on June 28 and 29

The Society for Pharmaceutical Dissolution Science (SPDS) will be holding its 6th Annual International Convention Disso India - Hyderabad 2018 on ...
Read more: Disso India - Hyderabad 2018 to take place on June 28 and 29

Pharma Reviews: Pricey Prescription

Indian pharma is on edge with an expected pharma pricing overhaul, but nothing is known yet on the shape of things to come. Industry sources say ...
Read more: Pricey Prescription

Pharma Reviews: US margins under stress, Indian drug makers get booster dose in Europe

While North American market may have dragged margins for Indian pharma in 2017-18 fiscal, most of the large caps seem to have done well in terms ...
Read more: US margins under stress, Indian drug makers get booster dose in Europe

Pharma Reviews: One year later, pharma industry bounces back to double-digit growth in May

Deepnath Roy Chowdhury, president of the Indian Drug Manufacturers' Association (IDMA), said it was a positive sign that the industry growth was ...
Read more: One year later, pharma industry bounces back to double-digit growth in May

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on new agency efforts to advance the patient voice in medical product development and FDA regulatory decision-making

FDA issues draft guidance on collecting patient experiences to inform the development and evaluation of medical products
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new agency efforts to advance the patient voice in medical product development and FDA regulatory decision-making

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s efforts to foster discovery and development of new tools to fight antimicrobial-resistant infections

The increase in serious antimicrobial drug resistant infections is a critical public health concern and a growing threat to patients. FDA is taking steps to combat antibiotic-resistant bacteria.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s efforts to foster discovery and development of new tools to fight antimicrobial-resistant infections

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to advance medical product communications to support drug competition and value-based health care

Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to advance medical product communications to support drug competition and value-based health care
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to advance medical product communications to support drug competition and value-based health care

Pharma Reviews: China to conduct training programmers for Indian pharmaceutical companies

The move assumes significance as it takes years for Indian pharmaceutical companies to obtain regulatory clearances for their products in China.
Read more: China to conduct training programmers for Indian pharmaceutical companies

Pharma Reviews: CPhI & P-MEC India 2018 shifts to Indian capital

The India Expo Mart brings the event closer to Indian regulatory and ... million venture capital fund to boost drug discovery and strengthen pharmaceutical ... The 2018 edition will also feature India Pharma Week (returning for a third ...
Read more: CPhI & P-MEC India 2018 shifts to Indian capital

Pharma Reviews: Why are India Medicines and Pharmaceutical Industry in High Demand in China?

India is growing leaps and bounds. India is taking long strides on the path to becoming a global superpower in pharmacy. The pharmaceutical industry ...
Read more: Why are India Medicines and Pharmaceutical Industry in High Demand in China?

Pharma Reviews: How decline in new product launches is impacting Indian pharma industry

The Indian pharma has recently seen a perceptible slide in the number of new products hitting the market. According to the analysts, slippages are ...
Read more: How decline in new product launches is impacting Indian pharma industry

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on 2017 National Youth Tobacco Survey results and ongoing FDA efforts to protect youth from the dangers of nicotine and tobacco products

Statement from FDA Commissioner Scott Gottlieb, M.D., on 2017 National Youth Tobacco Survey results and ongoing FDA efforts to protect youth from the dangers of nicotine and tobacco products
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on 2017 National Youth Tobacco Survey results and ongoing FDA efforts to protect youth from the dangers of nicotine and tobacco products

Pharma Reviews: Pharma experts address quality as a critical issue

In collaboration with the Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilisers, all the major industry associations, viz, the Indian ...
Read more: Pharma experts address quality as a critical issue

Pharma Reviews: Pharma industry needs to adopt global quality standards: OPPI

Mumbai, Jun 6 The Organisation of Pharmaceutical Producers of India (Oppi) today called for adopting global quality standards and bring all ...
Read more: Pharma industry needs to adopt global quality standards: OPPI

US FDA News: FDA Deputy Commissioner for Policy, Planning, Legislation, and Analysis Anna Abram, remarks prepared for testimony before a subcommittee of the U.S. House Committee on Energy and Commerce on the Pandemic and All-Hazards Preparedness Act

FDA’s Anna Abram’s testimony for U.S. House Committee on Energy and Commerce Subcommittee on Health on the Pandemic and All-Hazards Preparedness Act
Read more: FDA Deputy Commissioner for Policy, Planning, Legislation, and Analysis Anna Abram, remarks prepared for testimony before a subcommittee of the U.S. House Committee on Energy and Commerce on the Pandemic and All-Hazards Preparedness Act

Pharma Reviews: Pharma industry needs to adopt global quality standards: OPPI

The Organisation of Pharmaceutical Producers of India (Oppi) today called for adopting global quality standards and bring all stakeholders like ...
Read more: Pharma industry needs to adopt global quality standards: OPPI

Pharma Reviews: How Natco defied the odds to rise up India's pharma ladder

How Natco defied the odds to rise up India's pharma ladder ... Led by Nannapaneni, a formulation scientist, the company was never short of chemistry ...
Read more: How Natco defied the odds to rise up India's pharma ladder

Pharma Reviews: Sun Pharma closes over 3% higher after CLSA upgrades stock to 'buy'

The brokerage in a report said Indian pharma sector reported stable Q4 earnings on the back of stable US sales sequentially despite heightened ...
Read more: Sun Pharma closes over 3% higher after CLSA upgrades stock to 'buy'

Pharma Reviews: Exhibitions: Driving Indian Economic Growth & Competitiveness

The Indian exhibition market has witnessed a significant change and growth ... The Indian pharma industry is on the verge of transforming into a global ...
Read more: Exhibitions: Driving Indian Economic Growth & Competitiveness

Pharma Reviews: Sun Pharma climbs 2.5%; CLSA upgrades rating to 'buy'

CLSA says Indian pharma sector reported stable Q4 earnings on the back of stable US sales sequentially despite heightened pricing pressure, and ...
Read more: Sun Pharma climbs 2.5%; CLSA upgrades rating to 'buy'

Pharma Reviews: Investing in stock market? 10 things to look at when selecting a stock

However, generating profits from the stock market is not a child's play and ... Indian pharma companies are down since last the few quarters due to ...
Read more: Investing in stock market? 10 things to look at when selecting a stock

US FDA News: FDA takes action against 53 websites marketing unapproved opioids as part of a comprehensive effort to target illegal online sales

FDA announced that it has warned nine online networks, operating a total of 53 websites, that they must stop illegally marketing potentially dangerous, unapproved and misbranded versions of opioid medications, including tramadol and oxycodone.
Read more: FDA takes action against 53 websites marketing unapproved opioids as part of a comprehensive effort to target illegal online sales

US FDA News: FDA warns companies to stop selling dangerous and illegal pure and highly concentrated caffeine products

FDA issued warning letters to the parties responsible for liquidcaffeine.com and Dual Health Body and Mind for illegally selling certain highly concentrated caffeine products.
Read more: FDA warns companies to stop selling dangerous and illegal pure and highly concentrated caffeine products

Pharma Reviews: Sun rises with R&D and bets on specialty drugs

Success is also what Sun Pharmaceutical Industries, India's largest drug maker, seeks with Ilumya – no connection with the wizard – a treatment for ...
Read more: Sun rises with R&D and bets on specialty drugs

Pharma Reviews: Buy state-run banks, pharma with a 2-year views; these 4 monsoon picks could return up to 18%

US focused pharma players may continue to witness price erosion. Pharma players focused on the Indian market will continue to do well. One can ...
Read more: Buy state-run banks, pharma with a 2-year views; these 4 monsoon picks could return up to 18%

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on proposed modernization of FDA’s drug review office

FDA has proposed an important series of new steps to modernize the organization and functions of CDER’s Office of New Drugs.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on proposed modernization of FDA’s drug review office

Pharma Reviews: From Cipla to Glenmark, pharma companies' double-digit growth in doubt

Compliance and R&D costs in the India business are low and credit cycles are shorter and thus a rebound in the domestic market is important.
Read more: From Cipla to Glenmark, pharma companies' double-digit growth in doubt

Pharma Reviews: Government mulls new price index to regulate prices of drugs

The government is considering a new method to regulate prices of all medicines sold in India. Currently, only about 17% of the market and 24% of ...
Read more: Government mulls new price index to regulate prices of drugs

Pharma Reviews: Govt To Bring New Policy For Drug Pricing, But It's Not Clear If Medicines Will Be Cheaper

Among the changes proposed by the government is the move to introduce a new price index for pharmaceutical products that will become the ...
Read more: Govt To Bring New Policy For Drug Pricing, But It's Not Clear If Medicines Will Be Cheaper

Pharma Reviews: Govt may bring in new curbs on drug prices this month

The drug price regulator National Pharmaceutical Pricing Authority (NPPA) revises these prices annually based on the wholesale price index (WPI). For all ... For Indian pharma to be competitive on exports and earn valuable foreign ...
Read more: Govt may bring in new curbs on drug prices this month

US FDA News: STAT-Check and Medline Manual Resuscitator Bags by SunMed Holdings: Recall - Patient Port May Detach During Use

The patient port retaining ring of the affected bags may not fully seat which may allow the patient port to detach during use.
Read more: STAT-Check and Medline Manual Resuscitator Bags by SunMed Holdings: Recall - Patient Port May Detach During Use

Pharma Reviews: Pharma sector provides a good long-term opportunity: Sailesh Raj Bhan of Reliance Pharma Fund

India has high incidence of chronic diseases – diabetes, cardiac, thyroid, etc which needs pharmaceutical intervention to maintain quality of life.
Read more: Pharma sector provides a good long-term opportunity: Sailesh Raj Bhan of Reliance Pharma Fund

Pharma Reviews: Indian Drugmakers Expect Pricing Pressure To Continue In US

The companies, including global generic majors Teva Pharmaceutical ... Of the six largest Indian drugmakers, Sun Pharma and Cadila Healthcare ...
Read more: Indian Drugmakers Expect Pricing Pressure To Continue In US